MoneyWorks4Me

The sales declined to Rs. 3469.50 millions for the September 2024 quarter as compared to Rs. 4252.40 millions during the corresponding quarter last year.The Total Profit for the quarter ended September 2024 of Rs. 80.20 millions grew from Rs.-152.60 millionsOperating profit surged to 616.40 millions from the corresponding previous quarter of 389.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 3469.50 4252.40 -18.41 7104.40 7775.50 -8.63 12889.20 14438.10 -10.73
Other Income 3.20 12.30 -73.98 17.00 33.00 -48.48 53.70 221.40 -75.75
PBIDT 616.40 389.00 58.46 1052.60 601.10 75.11 -896.90 1561.80 -157.43
Interest 282.80 244.70 15.57 591.50 499.80 18.35 1059.70 900.60 17.67
PBDT 333.60 108.80 206.62 461.10 65.80 600.76 -3853.00 661.20 -682.73
Depreciation 253.40 261.40 -3.06 504.10 519.70 -3.00 1030.30 1109.00 -7.10
PBT 80.20 -152.60 -152.56 -43.00 -453.90 -90.53 -4883.30 -447.80 990.51
TAX 0.00 0.00 0.00 0.00 -102.50 0.00 785.40 -225.70 -447.98
Deferred Tax 0.00 0.00 0.00 0.00 -102.50 0.00 785.40 -224.60 -449.69
PAT 80.20 -152.60 -152.56 -43.00 -351.40 -87.76 -5668.70 -222.10 2452.32
Equity 402.10 360.00 11.69 402.10 360.00 11.69 360.00 360.00 0.00
PBIDTM(%) 17.77 9.15 94.21 14.82 7.73 91.65 -6.96 10.82 -164.33
Peers
Company Name CMP
Sun Pharma. Inds. 1848.10
Dr. Reddys Labs. 1197.50
Cipla 1408.00
Lupin 2083.55
Zydus Lifesciences 1191.20
View more..